GenSight Biologics S.A.

SIGHT.PA · PAR
Analyze with AI
6/30/2025
12/31/2024
6/30/2024
12/31/2023
Assets
Cash & Equivalents€270€2,464€6,940€2,134
Short-Term Investments€0€0€0€0
Receivables€1€1€35€1
Inventory€0€0€0€0
Other Curr. Assets€2,443€2,878€6,041€4,394
Total Curr. Assets€2,714€5,343€13,016€6,529
Property Plant & Equip (Net)€695€933€1,385€2,025
Goodwill€0€0€0€0
Intangibles€38€57€66€75
Long-Term Investments€3,903€4,423€519€503
Tax Assets€0€0€0€0
Other NC Assets€1€0€0€0
Total NC Assets€4,637€5,413€1,970€2,603
Other Assets€0€0€0€0
Total Assets€7,351€10,756€14,986€9,132
Liabilities
Payables€8,564€6,357€4,784€5,634
Short-Term Debt€13,957€13,899€6,665€17,380
Tax Payable€0€171€0€25
Deferred Revenue€0€0€1€1,881
Other Curr. Liab.€3,100€2,191€5,411€370
Total Curr. Liab.€25,621€22,618€16,861€25,290
LT Debt€5,056€5,214€16,016€1,048
Deferred Rev, NC€0€0€0€0
Deferred Tax Liab, NC€0€0€0€0
Other NC Liab.€8,780€9,844€6,943€13,462
Total NC Liab.€13,836€15,058€22,959€14,510
Other Liabilities€0€0€0€0
Cap. Leases€744€1,099€1,440€1,823
Total Liabilities€39,457€37,676€39,820€39,800
Equity
Pref Stock€0€0€0€197,052
Common Stock€3,287€3,119€2,596€1,633
Retained Earnings-€6,967-€14,001-€5,848-€26,220
AOCI-€236,184-€222,644-€222,981-€197,052
Other Equity€207,758€206,606€201,399-€6,115
Total Equity-€32,106-€26,920-€24,834-€30,668
Supplemental Information
Minority Interest€0€0€0€0
Total Liab. & Tot. Equity€7,351€10,756€14,986€9,132
Net Debt€18,743€16,649€15,741€16,294